Nathaniel Simons
Meritage Group
Nathaniel Simons Thermo Fisher Scientific Inc stake
total: 301
Meritage Group TMO trades
- Total transactions:
- 10
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 5
- Held since:
- 2017 Q3
- Held for:
- 10 quarters
- Latest activity:
- 2020 Q1
According to 2026 Q2 report, Nathaniel Simons doesn't hold any Thermo Fisher Scientific Inc (TMO) shares. To date, the estimated cost basis is nearly $204.62 for "buy" trades and estimated average "sell" price is $296.11. Meritage Group first purchased TMO in 2017 Q3, initially acquiring about 1.06M shares. Since the initial investment in Thermo Fisher Scientific Inc (TMO), Meritage Group has made 9 more transactions.
When did Nathaniel Simons sell Thermo Fisher Scientific Inc (TMO)?
Nathaniel Simons sold off the entire Thermo Fisher Scientific Inc (TMO) position in 2020 Q1.
When did Nathaniel Simons buy Thermo Fisher Scientific Inc (TMO)?
Nathaniel Simons first invested in Thermo Fisher Scientific Inc (TMO) in 2017 Q3 at the reported quarter-end price of $189.20 per share.
What's the cost basis of Meritage Group's TMO stake?
The estimated cost basis for Thermo Fisher Scientific Inc (TMO) stake is around $204.62 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $204.62
- Weighted AVG sell price:
- $296.11
Nathaniel Simons's historical trades in Thermo Fisher Scientific Inc
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q1
|
0.00%
|
$324.87
|
-100% (-821,795)
|
|||
|
2019 Q4
|
5.46%
|
$324.87
|
-9.69% (-88,162)
|
|||
|
2019 Q3
|
5.76%
|
$291.27
|
+26.30% (+189,478)
|
|||
|
2019 Q1
|
4.21%
|
$273.72
|
+0.33% (+2,351)
|
|||
|
2018 Q4
|
4.07%
|
$223.79
|
-18.86% (-166,868)
|
|||
|
2018 Q3
|
4.45%
|
$244.08
|
-8.14% (-78,433)
|
|||
|
2018 Q2
|
4.16%
|
$207.14
|
-9.02% (-95,556)
|
|||
|
2018 Q1
|
5.19%
|
$206.46
|
-1.58% (-16,990)
|
|||
|
2017 Q4
|
4.78%
|
$189.88
|
+1.09% (+11,581)
|
|||
|
2017 Q3
|
5.14%
|
$189.20
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.